News

Join the National Institute of Child Health and Human Development (NICHD)’s Dr. Tracey Rouault for a free webinar on a compound, TEMPOL, that could potentially be formulated into a preventative and oral treatment for COVID-19. When SARS-CoV-2 enters a host, the cells replicate it and viral particles
Inventors at the National Cancer Institute’s Laboratory of Molecular Biology have isolated three anti Programed Death-Ligand 1 (PD-L1) single domain antibodies that can be used as a therapeutic for treating solid tumors. An imbalance of PD-L1 contributes to cancer immune escape and it has been
Technology Transfer Central has selected Joseph M. Conrad, Ph.D. from the National Cancer Institute’s Invention Development and Marketing Unit (IDMU) to present a webinar focused on strategies to revitalize and expand a high-touch, low-tech approach to marketing technologies. This webinar will